These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1610551)
41. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy. Aubert G; Pozzetto B; Dorche G J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371 [TBL] [Abstract][Full Text] [Related]
42. First detection of metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia. Villegas MV; Lolans K; del Rosario Olivera M; Suarez CJ; Correa A; Queenan AM; Quinn JP; Antimicrob Agents Chemother; 2006 Jan; 50(1):226-9. PubMed ID: 16377690 [TBL] [Abstract][Full Text] [Related]
43. Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates. Lin SP; Liu MF; Lin CF; Shi ZY J Microbiol Immunol Infect; 2012 Jun; 45(3):200-7. PubMed ID: 22209695 [TBL] [Abstract][Full Text] [Related]
44. Isolation and properties of an inducible and a constitutive beta-lactamase from Pseudomonas aeruginosa. Berks M; Redhead K; Abraham EP J Gen Microbiol; 1982 Jan; 128(1):155-9. PubMed ID: 6806437 [TBL] [Abstract][Full Text] [Related]
45. Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Quinn JP; Studemeister AE; DiVincenzo CA; Lerner SA Rev Infect Dis; 1988; 10(4):892-8. PubMed ID: 3142013 [TBL] [Abstract][Full Text] [Related]
46. A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Navaneeth BV; Sridaran D; Sahay D; Belwadi MR Indian J Med Res; 2002 Dec; 116():264-7. PubMed ID: 12807154 [TBL] [Abstract][Full Text] [Related]
47. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012. Sefraoui I; Berrazeg M; Drissi M; Rolain JM Microb Drug Resist; 2014 Apr; 20(2):156-61. PubMed ID: 24320688 [TBL] [Abstract][Full Text] [Related]
48. Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa. Tsuchimochi N; Takuma T; Shimono N; Nagasaki Y; Uchida Y; Harada M J Infect Chemother; 2008 Apr; 14(2):99-104. PubMed ID: 18622671 [TBL] [Abstract][Full Text] [Related]
49. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa. Livermore DM; Yang YJ J Infect Dis; 1987 Apr; 155(4):775-82. PubMed ID: 3102630 [TBL] [Abstract][Full Text] [Related]
50. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases]. Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065 [TBL] [Abstract][Full Text] [Related]
51. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates. Altoparlak U; Aktas F; Celebi D; Ozkurt Z; Akcay MN Burns; 2005 Sep; 31(6):707-10. PubMed ID: 16129224 [TBL] [Abstract][Full Text] [Related]
53. Detection of metallo betalactamase producing Pseudomonas aeruginosa in hospitalized patients. Hemalatha V; Sekar U; Kamat V Indian J Med Res; 2005 Aug; 122(2):148-52. PubMed ID: 16177473 [TBL] [Abstract][Full Text] [Related]
54. Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa. Tam VH; Schilling AN; LaRocco MT; Gentry LO; Lolans K; Quinn JP; Garey KW Clin Microbiol Infect; 2007 Apr; 13(4):413-8. PubMed ID: 17359326 [TBL] [Abstract][Full Text] [Related]
55. [Participation of metallo-beta-lactamases in resistance to imipenem and meropenem in clinical strains of Pseudomonas aeruginosa and Acinetobacter spp]. Sacha P; Wieczorek P; Jakoniuk P; Zórawski M Wiad Lek; 2008; 61(1-3):30-6. PubMed ID: 18717040 [TBL] [Abstract][Full Text] [Related]
56. Diagnostic utility of combination of inducer and inhibitor based assay in detection of Pseudomonas aeruginosa producing AmpC β-lactamase. Upadhyay S; Sen MR; Bhattacharjee A; Prakash P; Bajpai RC; Anupurba S J Microbiol Methods; 2011 Oct; 87(1):116-8. PubMed ID: 21810447 [TBL] [Abstract][Full Text] [Related]
57. Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan. Kao CY; Chen SS; Hung KH; Wu HM; Hsueh PR; Yan JJ; Wu JJ BMC Microbiol; 2016 Jun; 16(1):107. PubMed ID: 27296461 [TBL] [Abstract][Full Text] [Related]
58. Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital. Cezário RC; Duarte De Morais L; Ferreira JC; Costa-Pinto RM; da Costa Darini AL; Gontijo-Filho PP Enferm Infecc Microbiol Clin; 2009 May; 27(5):269-74. PubMed ID: 19386392 [TBL] [Abstract][Full Text] [Related]
59. Purification and characterization of an imipenem hydrolysing metallo-beta-lactamase from Bacteroides fragilis. Hedberg M; Edlund C; Lindqvist L; Rylander M; Nord CE J Antimicrob Chemother; 1992 Feb; 29(2):105-13. PubMed ID: 1506324 [TBL] [Abstract][Full Text] [Related]
60. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea. Cho HH; Kwon GC; Kim S; Koo SH J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]